Cited by 510Bariatric Surgery and OutcomesObesity, Physical Activity, DietBody Contouring and Surgery

Life expectancy after bariatric surgery in the Swedish obese subjects study

Open access
Carlsson, Lena M.S., Sjöholm, Kajsa, Jacobson, Peter, Andersson-Assarsson, Johanna C., Svensson, Per-Arne, Taube, Magdalena, Carlsson, Björn, Peltonen, Markku·2020·New England Journal of Medicine

Abstract

BACKGROUND: Obesity shortens life expectancy. Bariatric surgery is known to reduce the long-term relative risk of death, but its effect on life expectancy is unclear. METHODS: We used the Gompertz proportional hazards regression model to compare mortality and life expectancy among patients treated with either bariatric surgery (surgery group) or usual obesity care (control group) in the prospective, controlled Swedish Obese Subjects (SOS) study and participants in the SOS reference study (reference cohort), a random sample from the general population. RESULTS: In total, 2007 and 2040 patients were included in the surgery group and the control group, respectively, and 1135 participants were included in the reference cohort. At the time of the analysis (December 31, 2018), the median duration of follow-up for mortality was 24 years (interquartile range, 22 to 27) in the surgery group and 22 years (interquartile range, 21 to 27) in the control group; data on mortality were available for 99.9% of patients in the study. In the SOS reference cohort, the median duration of follow-up was 20 years (interquartile range, 19 to 21), and data on mortality were available for 100% of participants. In total, 457 patients (22.8%) in the surgery group and 539 patients (26.4%) in the control group died (hazard ratio, 0.77; 95% confidence interval [CI], 0.68 to 0.87; P<0.001). The corresponding hazard ratio was 0.70 (95% CI, 0.57 to 0.85) for death from cardiovascular disease and 0.77 (95% CI, 0.61 to 0.96) for death from cancer. The adjusted median life expectancy in the surgery group was 3.0 years (95% CI, 1.8 to 4.2) longer than in the control group but 5.5 years shorter than in the general population. The 90-day postoperative mortality was 0.2%, and 2.9% of the patients in the surgery group underwent repeat surgery. CONCLUSIONS: Among patients with obesity, bariatric surgery was associated with longer life expectancy than usual obesity care. Mortality remained higher in both groups than in the general population. (Funded by the Swedish Research Council and others; SOS ClinicalTrials.gov number, NCT01479452.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2002449

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bariatric surgery and endoscopic procedures are important therapeutic options in people with type 2 diabetes and ABCD.

    “Bariatric surgery and endoscopic procedures are important therapeutic options in persons with T2D and ABCD.777–781”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [781]

    The Discussion (page not provided) reports longer life expectancy after bariatric surgery in middle-aged patients with severe obesity and notes trials examining type 2 diabetes remission. The Results—Participants section (page not provided) shows that the cohort included people with diabetes, but the paper does not address endoscopic procedures or establish the claim for all people with T2D and ABCD. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • In clinical trials comparing bariatric surgery with medical treatment in people with type 2 diabetes, bariatric surgery results in greater short-term and long-term lowering of A1C, including remission of type 2 diabetes in some people.

    “In clinical trials comparing bariatric surgery vs medical treatment in persons with T2D, bariatric surgery results in greater short-term and long-term lowering of A1C, including remission of T2D in some persons.777–783”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [781]

    The Discussion (page unavailable) says randomized trials have examined remission of type 2 diabetes after bariatric surgery, and the References list trials comparing surgery with medical treatment. This paper does not report the claimed greater short- or long-term A1C lowering or establish that remission occurred in some participants; its own outcome is life expectancy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • A particular advantage of bariatric surgery is successful long-term maintenance of large weight losses.

    “A particular advantage of bariatric surgery is the successful long-term maintenance of large weight losses, with data showing a mean BMI reduction of approximately 11 kg/m 2 at 1 year post-surgery, followed by a gradual weight regain on average until year 8, where it stabilized at approximately 7 kg/ m 2 less than the baseline BMI until 20 years post-surgery.98”
  • Large and sustained weight loss after bariatric surgery is accompanied by 23% and 30% reductions in all-cause and cardiovascular mortality, respectively, and a 3 year increase in life expectancy.

    “This large and sustained weight loss is accompanied by 23% and 30% reductions in all-cause and cardiovascular mortality, respectively, and a 3 year increase in life expectancy.98”
  • After bariatric surgery, cardiometabolic health, cancer risk, and life expectancy may improve dramatically even if BMI remains in the obesity range.

    “Maintaining a so-called normal body weight or BMI is unnecessary after having bariatric surgery as cardiometabolic health, cancer risk, and life expectancy may improve dramatically even if BMI remains in the obesity range (104–106).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carlsson, L. M. S., Sjöholm, K., Jacobson, P., Andersson-Assarsson, J. C., Svensson, P.-A., Taube, M., Carlsson, B., & Peltonen, M.
Affiliations
  • Karolinska Institutet (SE)
  • From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and...
Venue
New England Journal of Medicine
Published
2020-10-15
Volume
383
Issue
16
Pages
1535-1543
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3092759212
Cited by
509
References
29
Citations by year
2026: 69 · 2025: 83 · 2024: 84 · 2023: 98 · 2022: 83 · 2021: 81 · 2020: 9
FWCI
61.92
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
  • WOS
Funders
  • Swedish Research Council (2017-01707)
  • The Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement (ALFGBG-717881 and ALFGBG-717891)
  • The Swedish Diabetes Foundation (2019-417)
  • The Swedish Heart-Lung Foundation (20180410)
  • Novo Nordisk Fonden (NNF 19OC0057184)
  • the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (R01DK105948)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Surgery › Body Contouring and Surgery
Keywords
bariatric surgery, obesity, life expectancy, mortality, cardiovascular mortality, cancer mortality, Swedish Obese Subjects study, postoperative mortality, reoperation, general population comparison
MeSH terms
Adult, Female, Humans, Life Expectancy, Longevity, Male, Middle Aged, Obesity, Prospective Studies, Reoperation, Sweden, Proportional Hazards Models, Case-Control Studies, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review